Cargando…
NAD(P)H Quinone Oxidoreductase-1 Expression Promotes Self-Renewal and Therapeutic Resistance in Non-Small Cell Lung Cancer
Identifying cellular drivers responsible for enhancing cancer cell resistance to therapeutics provides critical information for designing more effective drugs. Populations of slowly growing, self-renewing, chemo-resistant cells purportedly contribute to the development of therapeutic resistance in m...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047941/ https://www.ncbi.nlm.nih.gov/pubmed/36980879 http://dx.doi.org/10.3390/genes14030607 |
_version_ | 1785014053669699584 |
---|---|
author | Madajewski, Brian Boatman, Michael A. Martinez, Ivan Carter, Julia H. Bey, Erik A. |
author_facet | Madajewski, Brian Boatman, Michael A. Martinez, Ivan Carter, Julia H. Bey, Erik A. |
author_sort | Madajewski, Brian |
collection | PubMed |
description | Identifying cellular drivers responsible for enhancing cancer cell resistance to therapeutics provides critical information for designing more effective drugs. Populations of slowly growing, self-renewing, chemo-resistant cells purportedly contribute to the development of therapeutic resistance in many solid tumors. In the current study, we implemented a tumor spheroid model to determine whether NAD(P)H quinone oxidoreductase-1 (NQO1) was requisite for self-renewal and promotion of the drug-resistant phenotype in non-small cell lung cancer (NSCLC). We found that stable depletion of NQO1 in A549 and H358 human NSCLC tumor models inhibits self-renewal capabilities, as demonstrated by a reduced ability to form primary, secondary, and tertiary spheroids. In contrast, the rescue of NQO1 expression restored the tumor cells’ ability to form spheroids. Additionally, we discovered that NQO1 depletion renders cisplatin-refractory tumor spheroids highly susceptible to drug treatment. Together, these results suggest that NQO1 loss reduces the self-renewing capabilities of NSCLC cells and enhances their susceptibility to clinically relevant therapeutics. These findings describe a novel role for NQO1 and suggest that combining NQO1-inhibitors with conventional chemotherapeutics may enhance anti-tumor effects. |
format | Online Article Text |
id | pubmed-10047941 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100479412023-03-29 NAD(P)H Quinone Oxidoreductase-1 Expression Promotes Self-Renewal and Therapeutic Resistance in Non-Small Cell Lung Cancer Madajewski, Brian Boatman, Michael A. Martinez, Ivan Carter, Julia H. Bey, Erik A. Genes (Basel) Article Identifying cellular drivers responsible for enhancing cancer cell resistance to therapeutics provides critical information for designing more effective drugs. Populations of slowly growing, self-renewing, chemo-resistant cells purportedly contribute to the development of therapeutic resistance in many solid tumors. In the current study, we implemented a tumor spheroid model to determine whether NAD(P)H quinone oxidoreductase-1 (NQO1) was requisite for self-renewal and promotion of the drug-resistant phenotype in non-small cell lung cancer (NSCLC). We found that stable depletion of NQO1 in A549 and H358 human NSCLC tumor models inhibits self-renewal capabilities, as demonstrated by a reduced ability to form primary, secondary, and tertiary spheroids. In contrast, the rescue of NQO1 expression restored the tumor cells’ ability to form spheroids. Additionally, we discovered that NQO1 depletion renders cisplatin-refractory tumor spheroids highly susceptible to drug treatment. Together, these results suggest that NQO1 loss reduces the self-renewing capabilities of NSCLC cells and enhances their susceptibility to clinically relevant therapeutics. These findings describe a novel role for NQO1 and suggest that combining NQO1-inhibitors with conventional chemotherapeutics may enhance anti-tumor effects. MDPI 2023-02-28 /pmc/articles/PMC10047941/ /pubmed/36980879 http://dx.doi.org/10.3390/genes14030607 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Madajewski, Brian Boatman, Michael A. Martinez, Ivan Carter, Julia H. Bey, Erik A. NAD(P)H Quinone Oxidoreductase-1 Expression Promotes Self-Renewal and Therapeutic Resistance in Non-Small Cell Lung Cancer |
title | NAD(P)H Quinone Oxidoreductase-1 Expression Promotes Self-Renewal and Therapeutic Resistance in Non-Small Cell Lung Cancer |
title_full | NAD(P)H Quinone Oxidoreductase-1 Expression Promotes Self-Renewal and Therapeutic Resistance in Non-Small Cell Lung Cancer |
title_fullStr | NAD(P)H Quinone Oxidoreductase-1 Expression Promotes Self-Renewal and Therapeutic Resistance in Non-Small Cell Lung Cancer |
title_full_unstemmed | NAD(P)H Quinone Oxidoreductase-1 Expression Promotes Self-Renewal and Therapeutic Resistance in Non-Small Cell Lung Cancer |
title_short | NAD(P)H Quinone Oxidoreductase-1 Expression Promotes Self-Renewal and Therapeutic Resistance in Non-Small Cell Lung Cancer |
title_sort | nad(p)h quinone oxidoreductase-1 expression promotes self-renewal and therapeutic resistance in non-small cell lung cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047941/ https://www.ncbi.nlm.nih.gov/pubmed/36980879 http://dx.doi.org/10.3390/genes14030607 |
work_keys_str_mv | AT madajewskibrian nadphquinoneoxidoreductase1expressionpromotesselfrenewalandtherapeuticresistanceinnonsmallcelllungcancer AT boatmanmichaela nadphquinoneoxidoreductase1expressionpromotesselfrenewalandtherapeuticresistanceinnonsmallcelllungcancer AT martinezivan nadphquinoneoxidoreductase1expressionpromotesselfrenewalandtherapeuticresistanceinnonsmallcelllungcancer AT carterjuliah nadphquinoneoxidoreductase1expressionpromotesselfrenewalandtherapeuticresistanceinnonsmallcelllungcancer AT beyerika nadphquinoneoxidoreductase1expressionpromotesselfrenewalandtherapeuticresistanceinnonsmallcelllungcancer |